Macrophages: Regulators of the inflammatory microenvironment during mammary gland development and breast cancer

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Brady, Nicholas J ^a   Chuntova, Pavlina ^a   Schwertfeger, Kathryn L ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST DEVELOPMENT; CELL INTERACTION; CELL POLARITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BREAST TUMOR; FEMALE; IMMUNOLOGY; MAMMARY GLAND; METABOLISM;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MACROPHAGES; MAMMARY GLANDS, HUMAN;

EID: 84958811760     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/4549676     Document Type: Review

References (134)

1. C. Schulz, E. G. Perdiguero, L. Chorro et al., "A lineage of myeloid cells independent of Myb and hematopoietic stem cells, " Science, vol. 335, no. 6077, pp. 86-90, 2012.
2. J. Y. Bertrand, A. Jalil, M. Klaine, S. Jung, A. Cumano, and I. Godin, "Three pathways to mature macrophages in the early mouse yolk sac, " Blood, vol. 106, no. 9, pp. 3004-3011, 2005.
3. D. Hashimoto, A. Chow, C. Noizat et al., "Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes, " Immunity, vol. 38, no. 4, pp. 792-804, 2013.
4. G. A. Challen, N. Boles, K. K. Lin, and M. A. Goodell, "Mouse hematopoietic stem cell identification and analysis, " Cytometry Part A, vol. 75, no. 1, pp. 14-24, 2009.
5. K. Akashi, D. Traver, T. Miyamoto, and I. L. Weissman, "A clonogenic common myeloid progenitor that gives rise to all myeloid lineages, " Nature, vol. 404, no. 6774, pp. 193-197, 2000.
6. D. K. Fogg, C. Sibon, C. Miled et al., "A clonogenic bone marrow progenitor specific for macrophages and dendritic cells, " Science, vol. 311, no. 5757, pp. 83-87, 2006.
7. J. Hettinger, D. M. Richards, J. Hansson et al., "Origin of monocytes and macrophages in a committed progenitor, " Nature Immunology, vol. 14, no. 8, pp. 821-830, 2013.
8. F. Geissmann, S. Jung, and D. R. Littman, "Blood monocytes consist of two principal subsets with distinct migratory properties, " Immunity, vol. 19, no. 1, pp. 71-82, 2003.
9. C. Auffray, D. Fogg, M. Garfa et al., "Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior, " Science, vol. 317, no. 5838, pp. 666-670, 2007.
10. B. Z. Qian, J. Li, H. Zhang et al., "CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, " Nature, vol. 475, no. 7355, pp. 222-225, 2011.
11. C. D. Conrady, M. Zheng, N. A. Mandal, N. van Rooijen, and D. J. Carr, "IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice, " Mucosal Immunology, vol. 6, no. 1, pp. 45-55, 2012.
12. K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, "Getting to the site of inflammation: the leukocyte adhesion cascade updated, " Nature Reviews Immunology, vol. 7, no. 9, pp. 678-689, 2007.
13. M. Sperandio, M. L. Smith, S. B. Forlow et al., "P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules, " Journal of Experimental Medicine, vol. 197, no. 10, pp. 1355-1363, 2003.
14. C. Berlin, R. F. Bargatze, J. J. Campbell et al., "α4 Integrins mediate lymphocyte attachment and rolling under physiologic flow, " Cell, vol. 80, no. 3, pp. 413-422, 1995.
15. J. R. Chan, S. J. Hyduk, and M. I. Cybulsky, "Chemoattractants induce a rapid and transient upregulation of monocyte α4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration, " Journal of Experimental Medicine, vol. 193, no. 10, pp. 1149-1158, 2001.
16. Y. Huo, A. Hafezi-Moghadam, and K. Ley, "Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions, " Circulation Research, vol. 87, no. 2, pp. 153-159, 2000.
17. S. E. Webb, J. W. Pollard, and G. E. Jones, "Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1, " Journal of Cell Science, vol. 109, no. 4, pp. 793-803, 1996.
18. R. J. Tushinski, I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley, "Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy, " Cell, vol. 28, no. 1, pp. 71-81, 1982.
19. A. Sica and A. Mantovani, "Macrophage plasticity and polarization: in vivo veritas, " Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012.
20. C. A. Janeway Jr. and R. Medzhitov, "Innate immune recognition, " Annual Review of Immunology, vol. 20, pp. 197-216, 2002.
21. H. Hemmi, O. Takeuchi, T. Kawai et al., "A toll-like receptor recognizes bacterial DNA, " Nature, vol. 408, no. 6813, pp. 740-745, 2000.
22. G. Raes, P. De Baetselier, W. Noël, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh, "Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages, " Journal of Leukocyte Biology, vol. 71, no. 4, pp. 597-602, 2002.
23. C. Schebesch, V. Kodelja, C. Müller et al., "Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro, " Immunology, vol. 92, no. 4, pp. 478-486, 1997.
24. E. Y. Chu, J. Hens, T. Andl et al., "Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis, " Development, vol. 131, no. 19, pp. 4819-4829, 2004.
25. P. Cowin and J. Wysolmerski, "Molecular mechanisms guiding embryonic mammary gland development, " Cold Spring Harbor Perspectives in Biology, vol. 2, no. 6, Article ID a003251, 2010.
26. J. M. Veltmaat, W. Van Veelen, J. P. Thiery, and S. Bellusci, "Identification of the mammary line in mouse by Wnt10b expression, " Developmental Dynamics, vol. 229, no. 2, pp. 349-356, 2004.
27. L. Hennighausen and G. W. Robinson, "Information networks in themammary gland, " Nature Reviews Molecular Cell Biology, vol. 6, no. 9, pp. 715-725, 2005.
28. R. C. Humphreys, M. Krajewska, S. Krnacik et al., "Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis, " Development, vol. 122, no. 12, pp. 4013-4022, 1996.
29. L. Bai and L. R. Rohrschneider, "s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue, " Genes & Development, vol. 24, no. 17, pp. 1882-1892, 2010.
30. N. J. Kenney, G. H. Smith, E. Lawrence, J. C. Barrett, and D. S. Salomon, "Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland, " Journal of Biomedicine and Biotechnology, vol. 1, no. 3, pp. 133-143, 2001.
31. J. E. Fata, V. Chaudhary, and R. Khokha, "Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle, " Biology of Reproduction, vol. 65, no. 3, pp. 680-688, 2001.
32. R. Ramakrishnan, S. A. Khan, and S. Badve, "Morphological changes in breast tissue with menstrual cycle, " Modern Pathology, vol. 15, no. 12, pp. 1348-1356, 2002.
33. Y. Cui, G. Riedlinger, K. Miyoshi et al., "Inactivation of stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation, " Molecular and Cellular Biology, vol. 24, no. 18, pp. 8037-8047, 2004.
34. X. W. Liu, G. W. Robinson, K.-U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen, "Stat5a is mandatory for adult mammary gland development and lactogenesis, " Genes & Development, vol. 11, no. 2, pp. 179-186, 1997.
35. C. J. Watson, "Key stages in mammary gland development-involution: apoptosis and tissue remodelling that convert the mammary gland frommilk factory to a quiescent organ, " Breast Cancer Research, vol. 8, no. 2, article 203, 2006.
36. W. T. Khaled, E. K. C. Read, S. E. Nicholson et al., "The IL-4/IL-13/stat6 signalling pathway promotes luminal mammary epithelial cell development, " Development, vol. 134, no. 15, pp. 2739-2750, 2007.
37. S. Mallepell, A. Krust, P. Chambon, and C. Brisken, "Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2196-2201, 2006.
38. R. C. Humphreys, J. Lydon, B. W. O'Malley, and J. M. Rosen, "Mammary gland development is mediated by both stromal and epithelial progesterone receptors, " Molecular Endocrinology, vol. 11, no. 6, pp. 801-811, 1997.
39. R. B. Clarke, A. Howell, C. S. Potten, and E. Anderson, "Dissociation between steroid receptor expression and cell proliferation in the human breast, " Cancer Research, vol. 57, no. 22, pp. 4987-4991, 1997.
40. J. M. Rosen and K. Roarty, "Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity?" Breast Cancer Research, vol. 16, no. 1, article 202, 2014.
41. J. Russo, X. Ao, C. Grill, and I. H. Russo, "Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor in relation to proliferating cells in the mammary gland, " Breast Cancer Research and Treatment, vol. 53, no. 3, pp. 217-227, 1999.
42. A. R. Thomsen, K. Almstrup, J. E. Nielsen et al., "Estrogenic effect of soy isoflavones on mammary glandmorphogenesis and gene expression profile, " Toxicological Sciences, vol. 93, no. 2, pp. 357-368, 2006.
43. K. L. Schwertfeger, J. M. Rosen, and D. A. Cohen, "Mammary gland macrophages: pleiotropic functions in mammary development, " Journal of Mammary Gland Biology and Neoplasia, vol. 11, no. 3-4, pp. 229-238, 2006.
44. V. Gouon-Evans, E. Y. Lin, and J. W. Pollard, "Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development, " Breast Cancer Research, vol. 4, no. 4, pp. 155-164, 2002.
45. V. Gouon-Evans, M. E. Rothenberg, and J. W. Pollard, "Postnatal mammary gland development requires macrophages and eosinophils, " Development, vol. 127, no. 11, pp. 2269-2282, 2000.
46. C. Riollet, P. Rainard, and B. Poutrel, "Cells and cytokines in inflammatory secretions of bovine mammary gland, " in Biology of the Mammary Gland, vol. 480 of Advances in Experimental Medicine and Biology, chapter 30, pp. 247-258, Springer, New York, NY, USA, 2000.
47. H. A. Martinson, S. Jindal, C. Durand-Rougely, V. F. Borges, and P. Schedin, "Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression, " International Journal of Cancer, vol. 136, no. 8, pp. 1803-1813, 2015.
48. J. OBrien, H. Martinson, C. Durand-Rougely, and P. Schedin, "Macrophages are crucial for epithelial cell death and adipocyte repopulation duringmammary gland involution, " Development, vol. 139, no. 2, pp. 269-275, 2012.
49. A. Van Nguyen and J. W. Pollard, "Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth, " Developmental Biology, vol. 247, no. 1, pp. 11-25, 2002.
50. W. V. Ingman, J. Wyckoff, V. Gouon-Evans, J. Condeelis, and J. W. Pollard, "Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland, " Developmental Dynamics, vol. 235, no. 12, pp. 3222-3229, 2006.
51. A. C. L. Chua, L. J. Hodson, L. M. Moldenhauer, S. A. Robertson, and W. V. Ingman, "Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium, " Development, vol. 137, no. 24, pp. 4229-4238, 2010.
52. L. J. Hodson, A. C. L. Chua, A. Evdokiou, S. A. Robertson, and W. V. Ingman, "Macrophage phenotype in the mammary gland fluctuates over the course of the estrous cycle and is regulated by ovarian steroid hormones, " Biology of Reproduction, vol. 89, no. 3, article 65, 2013.
53. L. C. Davies and P. R. Taylor, "Tissue-resident macrophages: then and now, " Immunology, vol. 144, no. 4, pp. 541-548, 2000.
54. J. Newson, M. Stables, E. Karra et al., "Resolution of acute inflammation bridges the gap between innate and adaptive immunity, " Blood, vol. 124, no. 11, pp. 1748-1764, 2014.
55. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, "Macrophage polarization: tumor-associated macrophages as a paradigmfor polarizedM2mononuclear phagocytes, " Trends in Immunology, vol. 23, no. 11, pp. 549-555, 2002.
56. J. E. Fata, Z. Werb, and M. J. Bissell, "Regulation of mammary gland branchingmorphogenesis by the extracellular matrix and its remodeling enzymes, " Breast Cancer Research, vol. 6, no. 1, pp. 1-11, 2004.
57. F. Lanigan, D. OConnor, E. Martin, and W. M. Gallagher, "Molecular links between mammary gland development and breast cancer, " Cellular and Molecular Life Sciences, vol. 64, no. 24, pp. 3161-3184, 1900.
58. X. Zhi, J. Tao, K. Xie, Y. Zhu, Z. Li, J. Tang et al., "MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer, " Cancer Letters, vol. 346, no. 1, pp. 104-113, 2014.
59. J. P. Witty, J. H. Wright, and L. M. Matrisian, "Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development, " Molecular Biology of the Cell, vol. 6, no. 10, pp. 1287-1303, 1995.
60. M. Gil, W. Yue, R. J. Santen et al., "Macrophages, estrogen and the microenvironment of breast cancer, " Journal of Steroid Biochemistry andMolecular Biology, vol. 67, no. 5-6, pp. 403-411, 1998.
61. L. M. Coussens and Z. Werb, "Inflammation and cancer, " Nature, vol. 420, no. 6917, pp. 860-867, 2002.
62. K. E. deVisser, L. V. Korets, and L. M. Coussens, "De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent, " Cancer Cell, vol. 7, no. 5, pp. 411-423, 2005.
63. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation, " Cell, vol. 144, no. 5, pp. 646-674, 2011.
64. M. Schäfer and S. Werner, "Cancer as an overhealing wound: an old hypothesis revisited, "Nature Reviews Molecular Cell Biology, vol. 9, no. 8, pp. 628-638, 2008.
65. E. J. Park, J. H. Lee, G. Y. Yu et al., "Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, " Cell, vol. 140, no. 2, pp. 197-208, 2010.
66. W. Strober, F. Zhang, A. Kitani, I. Fuss, and S. Fichtner-Feigl, "Proinflammatory cytokines underlying the inflammation of Crohns disease, " Current Opinion in Gastroenterology, vol. 26, no. 4, pp. 310-317, 2010.
67. C. L. Ogden, M. D. Carroll, B. K. Kit, and K. M. Flegal, "Prevalence of childhood and adult obesity in the United States, 2011-2012, " The Journal of the American Medical Association, vol. 311, no. 8, pp. 806-814, 2014.
68. L. W. Bowers, A. J. Brenner, S. D. Hursting, R. R. Tekmal, and L. A. deGraffenried, "Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production, " Breast Cancer Research and Treatment, vol. 149, no. 1, pp. 49-57, 2015.
69. X. Z. Sun, P. Casbas-Hernandez, C. Bigelow et al., "Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression, " Breast Cancer Research and Treatment, vol. 131, no. 3, pp. 1003-1012, 2012.
70. J. Ahn, A. Schatzkin, J. V. Lacey Jr. et al., "Adiposity, adult weight change, and postmenopausal breast cancer risk, " Archives of Internal Medicine, vol. 167, no. 19, pp. 2091-2102, 2007.
71. Q. Che, B.-Y. Liu, Y. Liao et al., "Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17β-estradiol biosynthesis in endometrial carcinoma microenvironment, " International Journal of Cancer, vol. 135, no. 2, pp. 282-294, 2014.
72. L. Dodds, D. B. Fell, K. S. Joseph et al., "Relationship of time since childbirth and other pregnancy factors to premenopausal breast cancer prognosis, " Obstetrics & Gynecology, vol. 111, no. 5, pp. 1167-1173, 2008.
73. T. R. Lyons, J. OBrien, V. F. Borges et al., "Postpartummammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2, " Nature Medicine, vol. 17, no. 9, pp. 1109-1116, 2011.
74. L. Bingle, N. J. Brown, and C. E. Lewis, "The role of tumourassociated macrophages in tumour progression: implications for new anticancer therapies, " The Journal of Pathology, vol. 196, no. 3, pp. 254-265, 2002.
75. R. D. Leek, C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris, "Association ofmacrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, " Cancer Research, vol. 56, no. 20, pp. 4625-4629, 1996.
76. S. M. Mahmoud, A. H. Lee, E. C. Paish, R. D. Macmillan, I. O. Ellis, and A. R. Green, "Tumour-infiltrating macrophages and clinical outcome in breast cancer, " Journal of Clinical Pathology, vol. 65, no. 2, pp. 159-163, 2012.
77. J. Condeelis and J. W. Pollard, "Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, " Cell, vol. 124, no. 2, pp. 263-266, 2006.
78. F. Balkwill, K. A. Charles, and A. Mantovani, "Smoldering and polarized inflammation in the initiation and promotion of malignant disease, " Cancer Cell, vol. 7, no. 3, pp. 211-217, 2005.
79. B. Z. Qian and J. W. Pollard, "Macrophage diversity enhances tumor progression and metastasis, " Cell, vol. 141, no. 1, pp. 39-51, 2010.
80. C. Murdoch, M. Muthana, S. B. Coffelt, and C. E. Lewis, "The role of myeloid cells in the promotion of tumour angiogenesis, " Nature Reviews Cancer, vol. 8, no. 8, pp. 618-631, 2008.
81. M. Liguori, G. Solinas, G. Germano, A. Mantovani, and P. Allavena, "Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma, " Cancers, vol. 3, no. 4, pp. 3740-3761, 2011.
82. L. R. Bohrer and K. L. Schwertfeger, "Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner, " Molecular Cancer Research, vol. 10, no. 10, pp. 1294-1305, 2012.
83. C. Lamagna, M. Aurrand-Lions, and B. A. Imhof, "Dual role of macrophages in tumor growth and angiogenesis, " Journal of Leukocyte Biology, vol. 80, no. 4, pp. 705-713, 2006.
84. J. Wyckoff, W. Wang, E. Y. Lin et al., "A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors, " Cancer Research, vol. 64, no. 19, pp. 7022-7029, 2004.
85. M. Lohela, A. Casbon, A. Olow et al., "Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 47, pp. E5086-E5095, 2014.
86. B. Ruffell and L. M. Coussens, "Macrophages and therapeutic resistance in cancer, " Cancer Cell, vol. 27, no. 4, pp. 462-472, 2015.
87. A. L. Doedens, C. Stockmann, M. P. Rubinstein et al., "Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression, " Cancer Research, vol. 70, no. 19, pp. 7465-7475, 2010.
88. B. Ruffell, D. Chang-Strachan, V. Chan et al., "Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells, " Cancer Cell, vol. 26, no. 5, pp. 623-637, 2014.
89. D. G. DeNardo, J. B. Barreto, P. Andreu et al., "CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, " Cancer Cell, vol. 16, no. 2, pp. 91-102, 2009.
90. E. Y. Lin, J.-F. Li, L. Gnatovskiy et al., "Macrophages regulate the angiogenic switch in a mouse model of breast cancer, " Cancer Research, vol. 66, no. 23, pp. 11238-11246, 2006.
91. P. Tymoszuk, H. Evens, V. Marzola et al., "In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors, " European Journal of Immunology, vol. 44, no. 8, pp. 2247-2262, 2014.
92. R. A. Franklin, W. Liao, A. Sarkar, M. V. Kim, M. R. Bivona, K. Liu et al., "The cellular and molecular origin of tumorassociated macrophages, " Science, vol. 344, no. 6186, pp. 921-925, 2014.
93. M. J. Campbell, N. Y. Tonlaar, E. R. Garwood et al., "Proliferatingmacrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome, " Breast Cancer Research and Treatment, vol. 128, no. 3, pp. 703-711, 2011.
94. C. H. Ries, M. A. Cannarile, S. Hoves et al., "Targeting tumorassociated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, " Cancer Cell, vol. 25, no. 6, pp. 846-859, 2014.
95. J. M. Low-Marchelli, V. C. Ardi, E. A. Vizcarra, N. van Rooijen, J. P. Quigley, and J. Yang, "Twist1 induces CCL2 and recruits macrophages to promote angiogenesis, " Cancer Research, vol. 73, no. 2, pp. 662-671, 2013.
96. J. L. Steiner and E. A. Murphy, "Importance of chemokine (CCmotif) ligand 2 in breast cancer, " The International Journal of Biological Markers, vol. 27, no. 3, pp. e179-e185, 2012.
97. G. Soria and A. Ben-Baruch, "The inflammatory chemokines CCL2 and CCL5 in breast cancer, " Cancer Letters, vol. 267, no. 2, pp. 271-285, 2008.
98. S. Svensson, A. Abrahamsson, G. V. Rodriguez et al., "CCL2 and CCL5 are novel therapeutic targets for estrogen-dependent breast cancer, " Clinical Cancer Research, vol. 21, no. 16, pp. 3794-3805, 2015.
99. T. Kitamura, B.-Z. Qian, D. Soong et al., "CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages, " The Journal of Experimental Medicine, vol. 212, no. 7, pp. 1043-1059, 2015.
100. L. Bonapace, M. M. Coissieux, J. Wyckoff et al., "Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis, " Nature, vol. 515, no. 7525, pp. 130-133, 2014.
101. J. R. Reed, M. D. Stone, T. C. Beadnell, Y. Ryu, T. J. Griffin, and K. L. Schwertfeger, "Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner, " PLoS ONE, vol. 7, no. 9, Article ID e45877, 2012.
102. J. Y. S. Tsang, Y.-B. Ni, S.-K. Chan et al., "CX3CL1 expression is associated with poor outcome in breast cancer patients, " Breast Cancer Research and Treatment, vol. 140, no. 3, pp. 495-504, 2013.
103. S. T. Boyle, J. W. Faulkner, S. R. McColl, and M. Kochetkova, "The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages, " Molecular Cancer, vol. 14, article 115, 2015.
104. C. E. Lewis and R. Hughes, "Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2, " Breast Cancer Research, vol. 9, no. 3, article 209, 2007.
105. C. Murdoch, A. Giannoudis, and C. E. Lewis, "Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues, " Blood, vol. 104, no. 8, pp. 2224-2234, 2004.
106. A. Casazza, D. Laoui, M. Wenes et al., "Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity, " Cancer Cell, vol. 24, no. 6, pp. 695-709, 2013.
107. C. Tripathi, B. N. Tewari, R. K. Kanchan et al., "Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin, " Oncotarget, vol. 5, no. 14, pp. 5350-5368, 2014.
108. C. Katanov, S. Lerrer, Y. Liubomirski et al., "Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway, " Stem Cell Research &Therapy, vol. 6, article 87, 2015.
109. T. Yoshimura, O. M. Howard, T. Ito et al., "Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells, " PLoS ONE, vol. 8, no. 3, Article IDe58791, 2013.
110. M. W. Pickup, L. D. Hover, E. R. Polikowsky et al., "BMPR2 loss infibroblasts promotesmammary carcinomametastasis via increased inflammation, " Molecular Oncology, vol. 9, no. 1, pp. 179-191, 2015.
111. T. L. Adair-Kirk and R. M. Senior, "Fragments of extracellular matrix as mediators of inflammation, "The International Journal of Biochemistry & Cell Biology, vol. 40, no. 6-7, pp. 1101-1110, 2008.
112. J. OBrien, T. Lyons, J. Monks et al., "Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species, " The American Journal of Pathology, vol. 176, no. 3, pp. 1241-1255, 2010.
113. K. L. Schwertfeger, M. K. Cowman, P. G. Telmer, E. A. Turley, and J. B. McCarthy, "Hyaluronan, inflammation, and breast cancer progression, " Frontiers in Immunology, vol. 6, article 236, 2015.
114. A. Zaman, Z. Cui, J. P. Foley et al., "Expression and role of the hyaluronan receptor RHAMMin inflammation after bleomycin injury, " American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 5, pp. 447-454, 2005.
115. N. Kobayashi, S. Miyoshi, T. Mikami et al., "Hyaluronan deficiency in tumor stroma impairsmacrophage trafficking and tumor neovascularization, " Cancer Research, vol. 70, no. 18, pp. 7073-7083, 2010.
116. C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill, "M-1/M-2 macrophages and the Th1/Th2 paradigm, " The Journal of Immunology, vol. 164, no. 12, pp. 6166-6173, 2000.
117. C. F. Nathan, H. W. Murray, M. E. Wiebe, and B. Y. Rubin, "Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, " The Journal of Experimental Medicine, vol. 158, no. 3, pp. 670-689, 1983.
118. D. M. Mosser, "The many faces of macrophage activation, " Journal of Leukocyte Biology, vol. 73, no. 2, pp. 209-212, 2003.
119. P. J. Murray, J. E. Allen, S. K. Biswas et al., "Macrophage activation and polarization: nomenclature and experimental guidelines, " Immunity, vol. 41, no. 1, pp. 14-20, 2014.
120. J. E. Goldberg and K. L. Schwertfeger, "Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics, " Current Drug Targets, vol. 11, no. 9, pp. 1133-1146, 2010.
121. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati, "The chemokine systemin diverse forms ofmacrophage activation and polarization, " Trends in Immunology, vol. 25, no. 12, pp. 677-686, 2004.
122. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked?" Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
123. J. Xue, S. V. Schmidt, J. Sander et al., "Transcriptome-based network analysis reveals a spectrum model of human macrophage activation, " Immunity, vol. 40, no. 2, pp. 274-288, 2014.
124. K. Movahedi, D. Laoui, C. Gysemans et al., "Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes, " Cancer Research, vol. 70, no. 14, pp. 5728-5739, 2010.
125. Buldakov M, Zavyalova M, Krakhmal N, Telegina N, Vtorushin S, Mitrofanova I, Riabov V, Yin S, Song B, Cherdyntseva N, Kzhyshkowska J.CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer. Immunobiology 222(1), 2015,pp:31-38.
126. A. Gratchev, P. Guillot, N. Hakiy et al., "Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3, " Scandinavian Journal of Immunology, vol. 53, no. 4, pp. 386-392, 2001.
127. M. Schnoor, P. Cullen, J. Lorkowski et al., "Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity, " The Journal of Immunology, vol. 180, no. 8, pp. 5707-5719, 2008.
128. E. Karousou, M. L. DAngelo, K. Kouvidi et al., "Collagen VI and hyaluronan: the common role in breast cancer, " BioMed Research International, vol. 2014, Article ID 606458, 10 pages, 2014.
129. D. H. Madsen, D. Leonard, A. Masedunskas et al., "M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway, " The Journal of Cell Biology, vol. 202, no. 6, pp. 951-966, 2013.
130. M. K. Cowman, H. Lee, K. L. Schwertfeger, J. B. McCarthy, and E. A. Turley, "The content and size of hyaluronan in biological fluids and tissues, " Frontiers in Immunology, vol. 6, article 261, 2015.
131. M. Y. Chang, Y. Tanino, V. Vidova, M. G. Kinsella, C. K. Chan, P. Y. Johnson et al., "A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease, " Matrix Biology, vol. 34, pp. 1-12, 2014.
132. P. W. Noble, F. R. Lake, P. M. Henson, and D. W. Riches, "Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages, " Journal of Clinical Investigation, vol. 91, no. 6, pp. 2368-2377, 1993.
133. D.-M. Kuang, Y. Wu, N. Chen, J. Cheng, S.-M. Zhuang, and L. Zheng, "Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes, " Blood, vol. 110, no. 2, pp. 587-595, 2007.
134. M. Lenart, M. Rutkowska-Zapala, M. Baj-Krzyworzeka et al., "Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14++CD16-) monocytes via PI3K/Akt/mTOR-dependent signalling pathway, " Immunobiology, 2015.